Emodinamica, Dipartimento Cardio-Toraco-Vascolare, Ospedale dell'Angelo, AULSS3 Serenissima, Mestre - Venezia 30174, Italy.
Dipartimento di Scienze Cardiologiche, Toraciche e Vascolari, Policlinico Universitario di Padova, Centro Gallucci, Padova 35122, Italy.
Rev Cardiovasc Med. 2020 Mar 30;21(1):9-23. doi: 10.31083/j.rcm.2020.01.44.
Contrast-induced acute kidney injury (CI-AKI) is a serious complication that can affect outcome and prognosis of patients undergoing percutaneous diagnostic and interventional procedures in catheterization laboratories. There have been advancements in case definition and epidemiology. Additionally strategies have emerged that are positioned to have impact in the catheterization laboratory for patients undergoing cardiovascular procedures. The aim of this review is to provide the state-of-the-art of diagnosis, prevention and management of CI-AKI in interventional cardiology.
对比剂诱导的急性肾损伤(CI-AKI)是一种严重的并发症,可影响接受经皮诊断和介入治疗的导管室患者的结局和预后。目前在病例定义和流行病学方面已经取得了进展。此外,还出现了一些策略,有望在接受心血管介入治疗的患者的导管室中产生影响。本文旨在提供介入心脏病学中 CI-AKI 的诊断、预防和管理的最新进展。